1 active not recruiting, 1 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Active not recruiting 1 |
Follow TT-301: new trials by email Literature Review of TT-301 trials Research Report on TT-301
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Biomarker and Edema Attenuation in IntraCerebral Hemorrhage (BEACH) MW189, Saline - Intracerebral Hemorrhage | Phase 2 | Active not recruiting | Johns Hopkins University | 120 | 2022-10-10 | 2026-04-02 |
| A MAD Study of TT301/MW189 in Healthy Volunteers 0.075mg/kg TT301/MW189, 0.15mg/kg TT301MW189, 0.25mg/kg TT301/MW189 - Healthy Adult Volunteers | Phase 1 | Completed | Linda Van Eldik | 35 | 2017-03-20 | 2020-06-16 |
Brain Edema (1) · Cerebral Hemorrhage (1) · Neuroinflammatory Diseases (1)
Johns Hopkins University (1) · Linda Van Eldik (1)
United States (2)
Jeffrey T. Guptill, MD, MA,MHS (1) · Linda J. Van Eldik, PhD (1) · Linda Van Eldik (1)
PMID 32255549, PMID 37919545, PMID 40236420, PMID 41040632
R01AG069930 (1)